• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动态网络分析揭示了肺癌进展阶段的关键 microRNAs。

Dynamical network analysis reveals key microRNAs in progressive stages of lung cancer.

机构信息

The Key Laboratory of Biomedical Information Engineering of Ministry of Education, Institute of Health and Rehabilitation Science, School of Life Science and Technology, Xi'an Jiaotong University, The Key Laboratory of Neuro-informatics & Rehabilitation Engineering of Ministry of Civil Affairs, Xi'an, Shaanxi, P. R. China.

National Engineering Research Center for Healthcare Devices. Guangzhou, Guangdong, P.R. China.

出版信息

PLoS Comput Biol. 2020 May 19;16(5):e1007793. doi: 10.1371/journal.pcbi.1007793. eCollection 2020 May.

DOI:10.1371/journal.pcbi.1007793
PMID:32428028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7295246/
Abstract

Non-coding RNAs are fundamental to the competing endogenous RNA (CeRNA) hypothesis in oncology. Previous work focused on static CeRNA networks. We construct and analyze CeRNA networks for four sequential stages of lung adenocarcinoma (LUAD) based on multi-omics data of long non-coding RNAs (lncRNAs), microRNAs and mRNAs. We find that the networks possess a two-level bipartite structure: common competing endogenous network (CCEN) composed of an invariant set of microRNAs over all the stages and stage-dependent, unique competing endogenous networks (UCENs). A systematic enrichment analysis of the pathways of the mRNAs in CCEN reveals that they are strongly associated with cancer development. We also find that the microRNA-linked mRNAs from UCENs have a higher enrichment efficiency. A key finding is six microRNAs from CCEN that impact patient survival at all stages, and four microRNAs that affect the survival from a specific stage. The ten microRNAs can then serve as potential biomarkers and prognostic tools for LUAD.

摘要

非编码 RNA 是肿瘤竞争内源性 RNA (CeRNA) 假说的基础。以前的工作主要集中在静态 CeRNA 网络上。我们基于长非编码 RNA (lncRNA)、microRNA 和 mRNA 的多组学数据,构建和分析了肺腺癌 (LUAD) 四个连续阶段的 CeRNA 网络。我们发现这些网络具有两级二分结构: 由所有阶段不变的 microRNA 组成的常见竞争内源性网络 (CCEN) 和阶段依赖的、独特的竞争内源性网络 (UCEN)。对 CCEN 中 mRNAs 途径的系统富集分析表明,它们与癌症的发展密切相关。我们还发现,UCENs 中 microRNA 连接的 mRNAs 具有更高的富集效率。一个关键的发现是,CCEN 中的六个 microRNAs 影响所有阶段的患者生存,四个 microRNAs 影响特定阶段的生存。这十个 microRNAs 可以作为 LUAD 的潜在生物标志物和预后工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/206c05ca6d8e/pcbi.1007793.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/5ab16eed441d/pcbi.1007793.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/f5f02db692af/pcbi.1007793.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/001c848c1474/pcbi.1007793.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/849a335e7a18/pcbi.1007793.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/4e946557fa85/pcbi.1007793.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/bdfea9eb3882/pcbi.1007793.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/04ccb54aa99d/pcbi.1007793.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/8699f1318c9a/pcbi.1007793.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/d8873ac3c837/pcbi.1007793.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/206c05ca6d8e/pcbi.1007793.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/5ab16eed441d/pcbi.1007793.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/f5f02db692af/pcbi.1007793.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/001c848c1474/pcbi.1007793.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/849a335e7a18/pcbi.1007793.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/4e946557fa85/pcbi.1007793.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/bdfea9eb3882/pcbi.1007793.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/04ccb54aa99d/pcbi.1007793.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/8699f1318c9a/pcbi.1007793.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/d8873ac3c837/pcbi.1007793.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b54a/7295246/206c05ca6d8e/pcbi.1007793.g010.jpg

相似文献

1
Dynamical network analysis reveals key microRNAs in progressive stages of lung cancer.动态网络分析揭示了肺癌进展阶段的关键 microRNAs。
PLoS Comput Biol. 2020 May 19;16(5):e1007793. doi: 10.1371/journal.pcbi.1007793. eCollection 2020 May.
2
Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.基于异常 lncRNA-miRNA-mRNA 网络和 Cox 回归模型的肺腺癌预后生物标志物的综合分析。
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20191554.
3
Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).鉴定甲状腺癌中的 RNA 表达谱,构建 mRNA、长链非编码 RNA(lncRNA)和 microRNA(miRNA)的竞争性内源性 RNA(ceRNA)网络。
Med Sci Monit. 2019 Feb 12;25:1140-1154. doi: 10.12659/MSM.912450.
4
Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis.基于生物信息学分析的肺腺癌潜在预后生物标志物。
Biomed Res Int. 2021 Jan 14;2021:8859996. doi: 10.1155/2021/8859996. eCollection 2021.
5
Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.转移性肺腺癌中 ncRNA 相关 ceRNA 网络的表征。
J Cell Mol Med. 2020 Oct;24(20):11680-11690. doi: 10.1111/jcmm.15778. Epub 2020 Aug 29.
6
Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.构建并综合分析 ceRNA 网络,揭示肺腺癌潜在的预后生物标志物。
BMC Cancer. 2021 Jul 23;21(1):849. doi: 10.1186/s12885-021-08462-8.
7
Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis.通过干细胞指标分析鉴定肺腺癌中新型癌症干性相关 ceRNA 轴。
Oncol Res. 2021 Sep 7;28(7):715-729. doi: 10.3727/096504020X16037124605559. Epub 2020 Oct 26.
8
Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.三种新型竞争性内源性 RNA 生物标志物在肺腺癌中具有预后价值的综合分析。
Biomed Res Int. 2020 Aug 4;2020:2837906. doi: 10.1155/2020/2837906. eCollection 2020.
9
A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.肺腺癌中竞争性内源性 RNA 网络的构建与分析的综合研究。
Biochim Biophys Acta Proteins Proteom. 2020 Aug;1868(8):140444. doi: 10.1016/j.bbapap.2020.140444. Epub 2020 May 11.
10
Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.构建竞争性内源性 RNA 网络,使用非小细胞肺癌中差异表达的 lncRNA、miRNA 和 mRNA。
Oncol Rep. 2019 Dec;42(6):2402-2415. doi: 10.3892/or.2019.7378. Epub 2019 Oct 17.

引用本文的文献

1
Non-coding RNAs identification and regulatory networks in pathogen-host interaction in the microsporidia congenital infection.微孢子虫先天性感染中病原体-宿主相互作用中非编码 RNA 的鉴定和调控网络。
BMC Genomics. 2023 Jul 26;24(1):420. doi: 10.1186/s12864-023-09490-3.

本文引用的文献

1
pathCHEMO, a generalizable computational framework uncovers molecular pathways of chemoresistance in lung adenocarcinoma.pathCHEMO,一个可推广的计算框架,揭示了肺腺癌化疗耐药的分子途径。
Commun Biol. 2019 Sep 6;2:334. doi: 10.1038/s42003-019-0572-6. eCollection 2019.
2
Harnessing tipping points in complex ecological networks.利用复杂生态网络中的 tipping points。
J R Soc Interface. 2019 Sep 27;16(158):20190345. doi: 10.1098/rsif.2019.0345. Epub 2019 Sep 11.
3
Focus on the emerging new fields of Network Physiology and Network Medicine.
关注网络生理学和网络医学等新兴领域。
New J Phys. 2016 Oct;18. doi: 10.1088/1367-2630/18/10/100201.
4
Ailanthone exerts an antitumor function on the development of human lung cancer by upregulating microRNA-195.葶苈子通过上调 microRNA-195 发挥抑制人肺癌发展的抗肿瘤功能。
J Cell Biochem. 2019 Jun;120(6):10444-10451. doi: 10.1002/jcb.28329. Epub 2018 Dec 19.
5
microRNA-148a-3p inhibited the proliferation and epithelial-mesenchymal transition progression of non-small-cell lung cancer via modulating Ras/MAPK/Erk signaling.miRNA-148a-3p 通过调节 Ras/MAPK/Erk 信号通路抑制非小细胞肺癌的增殖和上皮-间充质转化进展。
J Cell Physiol. 2019 Aug;234(8):12786-12799. doi: 10.1002/jcp.27899. Epub 2018 Dec 10.
6
Downregulated miR-144-3p contributes to progression of lung adenocarcinoma through elevating the expression of EZH2.下调的 miR-144-3p 通过上调 EZH2 的表达促进肺腺癌的进展。
Cancer Med. 2018 Nov;7(11):5554-5566. doi: 10.1002/cam4.1714. Epub 2018 Oct 2.
7
MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2.miR-9 通过调控真核翻译起始因子 5A2 增强非小细胞肺癌细胞对顺铂的敏感性。
Biomed Res Int. 2018 Aug 5;2018:1769040. doi: 10.1155/2018/1769040. eCollection 2018.
8
Major component analysis of dynamic networks of physiologic organ interactions.生理器官相互作用动态网络的主成分分析
J Phys Conf Ser. 2015;640. doi: 10.1088/1742-6596/640/1/012013. Epub 2015 Sep 28.
9
Lico A Causes ER Stress and Apoptosis via Up-Regulating miR-144-3p in Human Lung Cancer Cell Line H292.甘草酸A通过上调人肺癌细胞系H292中的miR-144-3p引起内质网应激和细胞凋亡。
Front Pharmacol. 2018 Jul 31;9:837. doi: 10.3389/fphar.2018.00837. eCollection 2018.
10
Overview upon miR-21 in lung cancer: focus on NSCLC.miR-21 在肺癌中的研究概况:聚焦 NSCLC。
Cell Mol Life Sci. 2018 Oct;75(19):3539-3551. doi: 10.1007/s00018-018-2877-x. Epub 2018 Jul 20.